Ligand profile
CHEMBL1277617
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_03600 — putative oxidoreductase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1277617- UniProt (similar protein)
P14061- pchembl
- 8.220 (~6.0 nM)
- Target protein
- KP13_03600
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 57.5
- −1 ≤ LogP ≤ 5 4.20
- MW ≤ 500 Da 314.3
- LogP ≤ 5 4.20
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 57.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(c1cccc(O)c1)c1ccc(-c2cccc(O)c2F)s1O=C(c1cccc(O)c1)c1ccc(-c2cccc(O)c2F)s1
InChI=1S/C17H11FO3S/c18-16-12(5-2-6-13(16)20)14-7-8-15(22-14)17(21)10-3-1-4-11(19)9-10/h1-9,19-20HInChI=1S/C17H11FO3S/c18-16-12(5-2-6-13(16)20)14-7-8-15(22-14)17(21)10-3-1-4-11(19)9-10/h1-9,19-20H
RDAJIOLTWQMUSV-UHFFFAOYSA-NRDAJIOLTWQMUSV-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF00106
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1277617 →
- UniProt UniProt P14061 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1277617”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03600.
PDB 13
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).